“The U.S. Farm Bill that was up for renewal in September in the House of Representatives could have included policies to support farmers in developing countries in their efforts to grow enough food to feed the local population,” but “Congress allowed the Farm Bill to expire on Sept. 30,” Ruth Messinger, president of the American Jewish World Service (AJWS), writes in the Huffington Post’s “Religion” blog. “If Congress does not act quickly after the election to pass a new Farm Bill, the money that exists for emergency food aid will run out in 2013,” potentially putting “up to 30 million hungry people at risk in the event of a crisis,” she continues, adding, “The failure to renew and reform the Farm Bill would also mean a missed opportunity to help end global hunger in the long term through sustainable solutions.”
Programs, Funding & Financing
“With just over one year left to achieve its target of having some 1.1 million men circumcised as part of HIV prevention efforts, Kenya’s government is ramping up efforts to bring more men into clinics, compensating them for their time and encouraging them to bring friends in for the procedure,” IRIN reports. “Kenya has carried out an estimated 477,000 circumcisions since the program started in 2008, according to the government,” IRIN writes. “This figure does not include those in the private sector where voluntary medical male circumcision is also done,” Walter Obiero, the clinical manager at the Nyanza Reproductive Health Society, said, the news service adds. “In 2011, UNAIDS and [PEPFAR] launched a five-year plan to have more than 20 million men in 14 eastern and southern African countries undergo medical male circumcision by 2015,” IRIN notes, writing, “The government is considering integrating male circumcision, currently offered as part of its HIV prevention package, into outpatient services in public hospitals, as well as starting infant male circumcision, which studies have found to be cost-effective” (11/6).
Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday published Issue 201 of its “Global Fund Observer.” Among other articles, the issue features an article on a recently released Aidspan paper examining how the Global Fund calculates lives saved; a commentary on how the Global Fund’s new funding model will affect its Latin America and the Caribbean portfolio; and an article examining five new reports from the Office of the Inspector General (OIG) — “three on audits in Bangladesh, Djibouti and Ghana, and two on investigations in Djibouti and South Africa” (11/5).
IRIN examines the controversy surrounding the Affordable Medicines Facility-malaria (AMFm), writing, “The argument over the way it operates has reignited ahead of a board meeting of the [Global Fund to Fight AIDS, Tuberculosis and Malaria] on 14-15 November, which is due to assess the success of the project and its reliance on private sector providers.” The news service reports on an evaluation of AMFm published recently in the Lancet and another paper by Oxfam criticizing the facility. The Global Fund Board, which administers AMFm, “is meeting in nine days to decide whether AMF has worked as was intended, and whether it should be continued, scaled up, or abandoned altogether,” IRIN writes (11/5).
“[I]t has been a banner year for media attention, political will and global resources on family planning and women’s and girls’ rights and empowerment,” Ward Cates, president emeritus of FHI 360; Laneta Dorflinger, a scientist with FHI 360; and Kirsten Vogelsong, a senior program officer with the family planning division of the Bill & Melinda Gates Foundation, write in the Huffington Post “Global Motherhood” blog, noting the London Summit on Family Planning, World Contraception Day, and the inaugural International Day of the Girl Child. “To achieve the ambitious goals set forth by these international initiatives, however, the global health and development community must act on the current political momentum and not lose sight of the challenges that remain,” they state. Though there are “many contraceptive choices available to prevent unintended pregnancy,” access to contraception is limited for many women and “the currently available methods do not always meet their needs, preferences or budgets,” they write.
“Aid workers say child malnutrition is reaching emergency levels in northern Mali, which has been under the control of armed militant groups since April,” VOA News reports. “Brussels-based aid organization Medecins du Monde, or Doctors of the World, says malnutrition rates among children under the age of five in occupied northern Mali are reaching ‘alarming levels,'” the news service writes, adding, “The NGO says it found that 13.5 percent of those children in the far northern Kidal region are suffering from acute malnutrition,” which is “double last year’s rate and well over the World Health Organization’s 10 percent alert threshold” (Look, 11/2).
“Flooding in Haiti caused by Hurricane Sandy has triggered a surge in cholera, with three deaths and almost 300 suspected cases, adding to a death toll from the storm of 54,” the Financial Times reports (Mander, 11/2). “Already struggling to recover from the effects of Hurricane Isaac in August, which in turn set back rebuilding from the earthquake of January 2010, Haiti now faces renewed crises on multiple fronts,” PBS NewsHour’s “The Rundown” writes (Lazaro, 11/2). “Three days of torrential downpours and strong winds brought by Hurricane Sandy destroyed much of Haiti’s fragile agriculture and have put a million and a half Haitians at risk for hunger, the United Nations’ humanitarian-aid coordination office said over the weekend,” according to the Wall Street Journal, which notes, “Potential food-price increases worry international and Haitian officials” (Arnesen, 11/4).
Asia-Pacific Accounts For Second Highest Burden Of Malaria Outside Of Africa, RBM Partnership Report Says
At a meeting of leading malaria scientists, political leaders, and health experts in Sydney on Friday, the Roll Back Malaria Partnership released a new report (.pdf) showing that more than two billion people in the Asia-Pacific region are at risk of the disease, Agence France-Presse reports. “There were some 34 million cases of malaria outside Africa in 2010, claiming the lives of an estimated 46,000 people,” the news agency notes, adding, “The Asia-Pacific, which includes 20 malaria-endemic countries, accounted for 88 percent, or 30 million, of these cases and 91 percent, or 42,000, of the deaths” (Parry, 11/2).
In an interview with GlobalPost’s “Global Pulse” blog, Mario Raviglione, director of the WHO’s Stop TB Department, explains “why the fight against [tuberculosis (TB)] is at a crossroads.” Because of advances in diagnostics and treatment, “we have a possibility here of envisioning a much brighter future for TB care and control over the next few decades,” he says, according to the interview transcript. “On the other hand, we have a financial gap that we are estimating at about $3 billion out of the $8 billion that are necessary for care and control efforts in countries, plus another $1.4 billion gap in the area of research,” he continues. According to the transcript, Raviglione addresses “why the funding gap exists, what would help reduce it, and what’s at stake as we choose a path forward” (Judem, 11/1).
Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece (.pdf), “[W]e would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs.” He continues, “If we fail to attend to the ‘on-the-ground’ details of implementation, we risk dissipating the promise of new drugs, novel therapies, and enhanced interventions that could, in fact, lead us to an AIDS-free generation.”